Herein, we sought to discuss the current understanding of the molecular mechanisms of NF‐κB in diverse glioma microenvironments such as hypoxia, inflammation, and oxidative stress, and its function as a therapeutic target for antiangiogenic strategies aimed at glioma. Here, NFKB1 is linked to glioma.